Raffles Medical's Attributable Profit Up 22% in H2, 2025; Shares Up 6%

MT Newswires
02/23

Raffles Medical's (SGX:BSL) profit attributable to owners jumped 22% in the second half of 2025 to SG$38.5 million from SG$31.6 million a year earlier, according to a Monday filing with the Singapore Exchange.

Earnings per share rose to SG$0.0208 compared with SG$0.017 in the year-ago period.

Revenue inched up 0.3% year over year to SG$386.9 million from SG$385.9 million, following improved performances from the hospital services and insurance business segments.

The company declared an ordinary final dividend of SG$0.03 per share for the period, up from SG$0.025 per share a year earlier. The dividend will be paid on May 22.

Shares of the medical and health services company were up nearly 6% in Monday morning trading.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10